\n| Subject<\/td>\n | \nAnnouncement that the company's board of\r\ndirectors resolved cash capital increase by issuing\r\ncommon shares<\/pre>\n<\/td>\n<\/tr>\n\n| Date of events<\/td>\n | 2025\/11\/07<\/td>\n | To which item it meets<\/td>\n | paragraph 11<\/td>\n<\/tr>\n | \n| Statement<\/td>\n | \n1.Date of the board of directors resolution:2025\/11\/07\r\n2.Source of capital increase funds: Cash capital increase through issuance of common shares.\r\n3.Whether to adopt shelf registration (Yes, please state issuance period\/No):No\r\n4.Total monetary value of the issuance and number of shares issued (shares issued not including those distributed to employees if consisting in capital increase from earnings or capital surplus): Total par value of issued shares:Maximum to NT$170,000 thousand; Total issued shares:Maximum to 17,000 thousand common shares.\r\n5.If adopting shelf registration, monetary value and number of shares to be issued this time:Not Applicable\r\n6.The remaining monetary value and shares after this issuance when adopting shelf registration:Not Applicable\r\n7.Par value per share:NT$10\r\n8.Issue price: Once the registration is approved by the FSC, the Chairman is authorized to determine the issuance price after consulting with underwriters about current market condition and taking into consideration \u201dSelf-Regulatory Rules of the Taiwan Securities Association Underwriter Member to Assist Issuers in Raising and Issuing Securities.\u201d\r\n9.Number of shares subscribed for by or allocated to employees: According to Article 267 of the Company Act, 15% of the new shares shall be reserved for employees' subscription.\r\n10.Number of shares publicly sold: According to Article 28-1 of the Securities and Exchange Act, 10% of the new shares shall be reserved for the publicly sold.\r\n11.Ratio of shares subscribed by or allotted as stock dividends to existing shareholders: 75 % of the new shares shall be reserved for the existing shareholders according to the existing shareholders' shareholding percentage.\r\n12.Handling method for fractional shares and shares unsubscripted for by the deadline: Any fractional shares which are less than one full share, the shareholders concerned may arrange for pooling together of their fractional shares to form one full share within 5 days after the book closure date. The Chairman is authorized to allocate fractional shares and shares unsubscripted for by existing shareholders and employees to specific counterparties at the issue price.\r\n13.Rights and obligations of these newly issued shares: Rights and obligations are the same as the existing common shares.\r\n14.Utilization of the funds from the capital increase: Repayment of bank loans and replenishment of working capital\r\n15.Any other matters that need to be specified:\r\n(1)The Chairman will have full authority to make amendments or adjustments to contents of the capital increase plan, including source of fund, actual issuance plan, planned subjects, fund allocation and progress, expected\r\nbenefit, etc. due to market condition or regulatory changes.\r\n(2)After the capital increase proposal is approved by the authority, the Chairman is authorized to determine the subscription date, capital increase date and other matters related to capital increase.\r\n(3)In order to cooperate with the issuance matters related to the cash capital increase, the chairman of the Board is authorized to sign all contracts and documents related to the cash capital increase on behalf of the Company and handle related issuance matters on behalf of the Company.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":" SEQ_NO \u00a04 Date of announcement 2025\/11\/07 Time of announcement 19:02:18 Subject Announcement that the company’s board of directors resolved cash capital increase by issuing common shares Date of events 2025\/11\/07 To which item it meets paragraph 11 Statement 1.Date of the board of directors resolution:2025\/11\/07 2.Source of capital increase funds: Cash capital increase through …<\/p>\n Announcement that the company’s board of directors resolved cash capital increase by issuing common shares<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-10073","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/10073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=10073"}],"version-history":[{"count":2,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/10073\/revisions"}],"predecessor-version":[{"id":10096,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/10073\/revisions\/10096"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=10073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=10073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=10073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} | |